You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pralatrexate

Showing 26 - 41 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell Trial (Copanlisib, Romidepsin)

Withdrawn
  • Lymphoma, T-Cell
  • (no location specified)
Aug 11, 2020

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (carboplatin, pralatrexate, Folic Acid)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Dec 20, 2017

Pralatrexate for Relapsed or Refractory Peripheral T-cell

Completed
  • Relapsed or Refractory Peripheral T-cell Lymphoma
  • Pralatrexate
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
  • +1 more
Nov 23, 2017

Peripheral T-cell Lymphoma Trial in Nagoya, Chuo, Okayama, (Pralatrexate injection, Vitamin B12, Folic Acid)

Completed
  • Peripheral T-cell Lymphoma
  • Pralatrexate injection
  • +2 more
  • Nagoya, Aichi, Japan
  • +2 more
Nov 7, 2017

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Undifferentiated Carcinoma, Gastric Adenocarcinoma Trial in Buffalo,

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
  • +1 more
Nov 14, 2017

Peripheral T-Cell Lymphoma Trial in Worldwide

Recruiting
  • Peripheral T-Cell Lymphoma
    • Stanford, California
    • +5 more
    Jul 8, 2020

    Adult T-cell Leukemia-Lymphoma Trial in Worldwide (KW-0761, Pralatrexate, gemcitabine plus oxaliplatin)

    Completed
    Has Results
    • Adult T-cell Leukemia-Lymphoma
    • KW-0761
    • +3 more
    • Los Angeles, California
    • +19 more
    Aug 21, 2018

    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Worldwide (Alisertib, Pralatrexate,

    Completed
    Has Results
    • Relapsed Peripheral T-Cell Lymphoma
    • Refractory Peripheral T-Cell Lymphoma
    • Birmingham, Alabama
    • +151 more
    Jul 6, 2018

    Peripheral T Cell Lymphoma, Progression, Disease Trial in Taipei (Pralatrexate)

    Unknown status
    • Peripheral T Cell Lymphoma
    • Progression, Disease
    • Pralatrexate
    • Taipei, Taiwan
      Ntional Taiwan University Hospital
    May 10, 2017

    T-Cell Lymphoma, NK-Cell Lymphoma Trial in Hong Kong (pembrolizumab)

    Unknown status
    • T-Cell Lymphoma
    • NK-Cell Lymphoma
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Apr 15, 2019

    Multiple Myeloma Trial in Stanford (velcade, Pralatrexate)

    Completed
    • Multiple Myeloma
    • Stanford, California
      Stanford University School of Medicine
    Jul 5, 2016

    Advanced Cancers, Solid Tumors Trial in Houston (Erlotinib, Pralatrexate)

    Completed
    • Advanced Cancers
    • Solid Tumors
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jul 1, 2016

    Adenocarcinoma of the Esophagus, Adenocarcinomas of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in Columbus

    Completed
    Has Results
    • Adenocarcinoma of the Esophagus
    • +4 more
    • pralatrexate
    • +3 more
    • Columbus, Ohio
      Ohio State University
    Apr 25, 2016

    Head Neck Cancer Trial in United States (Pralatrexate With Vitamin B12 and Folic Acid)

    Completed
    Has Results
    • Head and Neck Cancer
    • Pralatrexate With Vitamin B12 and Folic Acid
    • Basking Ridge, New Jersey
    • +4 more
    Oct 19, 2015

    Solid Tumor Trial in New York (pralatrexate, probenecid)

    Completed
    • Unspecified Adult Solid Tumor, Protocol Specific
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 25, 2013

    Lung Cancer Trial in New York (pralatrexate)

    Completed
    • Lung Cancer
    • pralatrexate
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 18, 2013